Optinose Announces ReOpen2 Presentation at the American College of Asthma, Allergy, and Immunology (ACAAI) 2022 Annual Scientific Meeting
09 nov. 2022 15h00 HE
|
Optinose, Inc.
YARDLEY, Pa., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Optinose Announces Late Breaking Abstract Podium Presentation at IDWeek 2022
21 oct. 2022 07h00 HE
|
Optinose, Inc.
Presentation highlights a greater than 60% reduction in acute exacerbations and need for antibiotics for chronic sinusitis patients who used XHANCE in landmark ReOpen phase 3 clinical trial program ...
GeoVax Announces Upcoming Presentations at Scientific Conferences
04 mai 2022 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, May 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire –GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human vaccines and immunotherapies against infectious diseases...
vTv Therapeutics to Present Additional Positive Clinical Study Results from Phase 2 Simplici-T1 Study of TTP399 as Adjunctive Therapy for Patients with Type 1 Diabetes at EASD Virtual Meeting
16 sept. 2020 07h30 HE
|
vTv Therapeutics Inc.
HIGH POINT, N.C., Sept. 16, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced it will deliver two oral presentations emphasizing the potential of TTP399 as an oral...
vTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study in Patients with Type 1 Diabetes at 55th Annual Meeting of the European Association for the Study of Diabetes
18 sept. 2019 07h30 HE
|
vTv Therapeutics Inc.
HIGH POINT, N.C., Sept. 18, 2019 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), today presented additional positive data from its phase 2 Simplici-T1 study in patients with type 1...
vTv Therapeutics to Present Posters at Two Scientific Conferences in September
11 sept. 2019 07h30 HE
|
vTv Therapeutics Inc.
Presenting New Clinical Data from Phase 2 Study in Type 1 Diabetes with Liver Selective GKA Program Pre-Clinical Data in NASH with the NRF2/Bach1 Program HIGH POINT, N.C., Sept. 11, 2019 (GLOBE...
Ondine President, Dr. Nicolas Loebel, Plenary Speaker at the 17th World Congress of the International Photodynamic Association
24 juil. 2019 11h13 HE
|
Ondine Biomedical Inc.
Vancouver, Canada, July 24, 2019 (GLOBE NEWSWIRE) -- Recognized as a global expert in the emerging field of antimicrobial photodynamic therapy, Dr. Nicolas Loebel, President and Chief Technology...
Optinose to Highlight Data at Two Upcoming Scientific Meetings
03 oct. 2018 07h00 HE
|
OptiNose, Inc.
YARDLEY, Pa., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Immune Design Announces Multiple Presentations at CTOS and SITC Highlighting the Breadth of Existing & Future Product Candidates
07 nov. 2017 08h00 HE
|
Immune Design Corp.
SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today announced seven...
International Aquatic Conference Aims To Bring Leaders Together
17 mai 2016 14h31 HE
|
National Swimming Pool Foundation
COLORADO SPRINGS, Colo., May 17, 2016 (GLOBE NEWSWIRE) -- The World Aquatic Health™ Conference (WAHC), the leading educational and scientific conference in the aquatics industry, will be in...